← Back to Search

Diagnostic Test

Lung Ultrasound for Lung Transplant

N/A
Recruiting
Led By Tathagat Narula, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Asymptomatic
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 0 to month 12
Awards & highlights

Study Summary

This trial is testing a new, non-invasive way to diagnose lung rejection and infection.

Eligible Conditions
  • Post-Lung Transplant Bronchiectasis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You do not have any symptoms related to the medical condition being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 0 to month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 0 to month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Establish predictive value of lung ultrasound

Trial Design

1Treatment groups
Experimental Treatment
Group I: Receiving UltrasoundExperimental Treatment1 Intervention
Every patient will receive a lung ultrasound prior to each scheduled bronchoscopy until the study stops.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lung ultrasound
2021
N/A
~2160

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,766,994 Total Patients Enrolled
3 Trials studying Bronchiectasis
115 Patients Enrolled for Bronchiectasis
Tathagat Narula, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital Jacksonville

Media Library

Lung ultrasound (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT04582279 — N/A
Bronchiectasis Research Study Groups: Receiving Ultrasound
Bronchiectasis Clinical Trial 2023: Lung ultrasound Highlights & Side Effects. Trial Name: NCT04582279 — N/A
Lung ultrasound (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04582279 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment process for this trial still open to applicants?

"Affirmative. According to the information found on clinicaltrials.gov, this clinical study is currently seeking participants for enrollment. The trial was established on October 28th 2020 and most recently edited on June 9th 2022 with a target recruitment of 90 individuals from one location."

Answered by AI

What is the current capacity for participants in this clinical investigation?

"Affirmative, the information available on clinicaltrials.gov confirms that this medical research is actively accepting candidates. The study was initially launched on October 28th 2020 and has been updated as recently as June 9th 2022 with a goal of recruiting 90 patients from 1 site."

Answered by AI

Who else is applying?

What state do they live in?
Louisiana
How old are they?
65+
What site did they apply to?
Mayo Clinic in Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients
Tathagat Narula 2020. "Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04582279.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top